Skip to main content
Figure 1 | Cost Effectiveness and Resource Allocation

Figure 1

From: Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review

Figure 1

Flow chart of study selection. ADA = American Diabetes Association, DAHTA = Deutsche Agentur für Health Technology Assessment, DARE = National Health Service's Database of Abstracts of Reviews of Effects, DDG = Deutsche Diabetes Gesellschaft, EASD = European Association for the Study of Diabetes, GLA = Insulin glargine, GMS = German Medical Science, ISPOR = International Society for Pharmacoeconomics and Outcomes Research, NHS-EED = National Health Service Economic Evaluation Database, NHS-HTA = National Health Service Health Technology Assessment Database, NPH = Neutral Protamine Hagedorn insulin.

Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us